What replaced the rescue-inhaler-only asthma plan that global experts dropped

Key takeaways

• About 27.8 million Americans had asthma in 2023, and 3,624 died of it, or about 10 deaths a day by our math¹.
• The Global Initiative for Asthma (GINA) calls relying on a rescue inhaler alone a risk factor for attacks, and it links filling 12 or more rescue canisters a year to a higher risk of death⁴.
• In May 2026, GINA said children ages 6 to 11 should no longer be treated with a rescue inhaler alone, while U.S. guidelines from 2020 still list one alone as the first step for occasional asthma⁵⁶⁷.
• Call 911 if breathing is so hard that someone can’t walk or talk, if lips or fingernails turn blue or gray, or if the person becomes confused or less responsive⁸.
• Weight loss may help people with obesity and yoga probably helps a little, but the National Center for Complementary and Integrative Health says no supplement has clearly been shown to help asthma^10111213.

Twelve. That’s how many rescue inhalers a year an international panel of asthma experts links to a higher risk of dying from asthma⁴.

The panel is the Global Initiative for Asthma, or GINA, which updates its treatment strategy every year⁴. A summary of its 2025 report in The Lancet Respiratory Medicine didn’t soften the message. Leaning on a rescue inhaler as your only medicine, or reaching for it too often, counts as a risk factor for attacks and for asthma that never settles down⁴. The warning signs start well below 12: filling three or more canisters a year already goes with more emergency visits and hospital stays⁴⁶.

In May 2026, GINA extended that thinking to children ages 6 to 11. They, too, should no longer be treated with a rescue inhaler alone⁵⁶. U.S. guidelines haven’t gone as far, as you’ll see below⁷.

That matters in a country where about 27.8 million people have asthma and 3,624 died of it in 2023¹. By our math, that’s about 10 deaths a day.

Below: what asthma does to your airways, why the advice changed, how to tell a rough day from an emergency, and where natural approaches fit. They can sit alongside medicine; the evidence says they can’t replace it.

Asthma swells the airways, and attacks are still common

Asthma is a lasting disease of the tubes that carry air into the lungs, the National Heart, Lung, and Blood Institute (NHLBI) explains: they become inflamed and narrow¹⁵. That leaves them puffy and quick to react. When a trigger hits, the bands of muscle wrapped around them clamp down, and the lining may pour out extra mucus¹⁵.

You feel it as wheezing, coughing, a tight chest and shortness of breath¹⁵. There’s no cure, but NHLBI says most people with asthma can keep it in check¹⁵.

Two kinds of medicine do that work. Daily controllers go after the underlying inflammation so symptoms are less likely to start. Quick-relief, or “rescue,” inhalers are for fast help once symptoms flare¹⁵.

The numbers show how far from controlled many people are. In 2023, 42.3% of Americans with asthma had at least one attack, including 47.1% of children with asthma¹. Asthma was the main reason for about 1 million emergency room visits and about 132,000 hospital stays that year¹.

There is real progress. A 2024 CDC analysis found that the share of people with asthma who had an attack fell from 51.9% in 2010 to 39.4% in 2021². But the asthma death rate didn’t budge over those years².

The burden also falls unevenly. In 2021, Black adults died of asthma at a rate of 29.7 per million, compared with 11.8 per million for white adults². By our math, that’s about 2.5 times the rate. Black children were more than twice as likely as white children to have asthma, 12.5% versus 5.7%².

The costs reach past the clinic. The Environmental Protection Agency (EPA) estimates asthma cost the country more than $81.9 billion in 2013, counting medical care and missed school and work, and that asthma caused about 13.8 million missed school days³.

Why a rescue inhaler alone is no longer the standard

A rescue inhaler, such as albuterol (called salbutamol in many countries), eases symptoms when they flare¹⁵. In the language of the guidelines, it’s a short-acting beta agonist, or SABA⁴⁷. What it isn’t built to do is calm the inflammation underneath, which is the job of control medicines¹⁵.

GINA’s 2025 report treats rescue-only care as a risk factor in its own right⁴. Pharmacy records tell the story. In GINA’s reading of the data, the risk of an emergency visit or hospital stay goes up at three or more canisters a year, compared with zero to two. At 12 or more, and possibly fewer, the risk of dying from asthma rises⁴⁶.

These are links found in records, not proof that the inhaler itself causes harm. They do flag who needs a closer look.

GINA now lays out two treatment “tracks” for teens and adults⁴:

• Track 1, the preferred one: a single inhaler that combines an inhaled corticosteroid (ICS), a steroid that works in the airways, with formoterol, an airway opener. The one inhaler serves as both controller and reliever⁴.
• Track 2, the alternative: some other controller medicine, with a standard rescue inhaler kept on hand for flares. One reason it survives: in many low-income countries, the combined inhaler simply isn’t available⁴.

Why prefer Track 1? Compared with plans that rely on a standard rescue inhaler, using the steroid-formoterol inhaler for relief clearly lowers the chance of a severe attack or an urgent-care trip, GINA concluded in 2025⁴.

The 2026 report, published in May, went further for children⁵⁶. For ages 6 to 11, a rescue inhaler alone is no longer recommended. GINA’s 2026 guide says an as-needed, low-dose steroid-formoterol inhaler lowers this age group’s risk of attacks compared with a rescue inhaler alone⁶.

Trade-press coverage tied the change to a trial called CARE⁵. For teens and adults, the 2026 report also lists an inhaler that pairs a steroid with a standard rescue drug as a first-step option on Track 2⁵⁶.

U.S. guidance has moved only partway. NHLBI’s 2020 focused update to the national asthma guidelines strongly recommends one steroid-formoterol inhaler for daily and as-needed use in people 4 and older with moderate to severe persistent asthma⁷.

For people 12 and older with mild persistent asthma, it conditionally recommends either a daily low-dose steroid, with a rescue inhaler as needed, or a steroid inhaler used together with the rescue inhaler when symptoms strike⁷. But for intermittent asthma, the mildest kind, its step-by-step chart still lists a rescue inhaler alone as the preferred first step, for children 5 to 11 and for everyone 12 and older⁷. That update covered only selected topics, not a full rewrite of the 2007 guidelines⁷.

The two bodies differ by age, severity and wording, so your own written plan is what counts. If your only asthma medicine is a rescue inhaler, bring that up at your next visit. Don’t stop, start or switch any medicine on your own.

The asthma check-in: green, yellow or red

A written asthma action plan sorts how you’re doing into three zones. Many plans, including the Minnesota Department of Health’s adult plan used for the table below, also compare a peak flow reading with your personal best⁹. A peak flow meter is a small handheld device you blow into.

Use this check-in with your own plan. The steps inside each zone, including any medicine, should come from your clinician.

Check-in question	Green: doing well	Yellow: caution	Red: get help now
How is my breathing?	No cough or wheeze9	Some cough, wheeze or tight chest9	Many breathing problems, getting worse, or quick-relief medicine isn’t helping9
How are sleep and activity?	Sleeping well; can work and play9	May wake at night; trouble working or playing9	Can’t work or play9
What does my peak flow say?	Above 80% of my best9	50% to 79% of my best9	Below 50% of my best9
What do I do?	Keep following my daily plan9	Follow my yellow-zone steps; if I’m worse or still yellow after 24 hours, follow my red-zone steps and call my clinician right away9	Follow my red-zone steps; call 911 if red-zone symptoms last more than 15 minutes or any sign in the box below appears89
Yearly check: how many rescue canisters did I fill?	0 to 2 (our framing: GINA’s lower-risk comparison group, not a proven safe limit)6	3 or more goes with more emergency visits; review my plan with my clinician46	12 or more goes with a higher risk of death; review my plan with my clinician promptly46

One more check is cheap and quick: technique. GINA’s 2026 guide reminds people to shake the inhaler before every puff⁶. Ask your pharmacist or clinician to watch you use your inhaler.

What sets asthma off, and which triggers you can control

Americans spend about 90% of their time indoors, the EPA notes, and common indoor triggers include dust mites, mold, cockroaches, pet dander and secondhand smoke³.

Secondhand smoke deserves special mention. EPA says it can set off attacks, make them worse and raise the risk of new asthma in preschool children, whose faster breathing pulls in more of it¹⁴. GINA also lists smoking exposure as a risk factor for attacks⁴. Keeping smoke out of your home and car is one of the most natural steps a family can take¹⁴.

Allergen control pays off when it’s aimed at something you’ve been shown to react to, NHLBI’s 2020 update says⁷. Our companion article on indoor allergens covers where those allergens come from, what the guideline backs and which “hypoallergenic” claims hold up.

Other triggers, from respiratory infections to exercise and wildfire smoke, get their own articles in the library.

Natural approaches: what helps alongside medicine

The National Center for Complementary and Integrative Health (NCCIH), part of the National Institutes of Health, puts the main point simply. The research doesn’t back swapping complementary approaches in for proven asthma care¹⁰. But practices aimed at stress, anxiety or depression, used alongside medical care, might help people feel better and improve control¹⁰¹².

Weight loss has the most direct case for people with overweight or obesity. Cochrane reviewers, searching studies published through March 2012, turned up just four randomized trials, together enrolling 197 adults in Australia, Brazil, Finland and Mexico¹³. Participants exercised under supervision, cut calories, took weight-loss drugs, or did some mix of the three¹³.

Those programs did take weight off. Beyond that, the gains were scattered: better symptom scores in one trial, a short-term drop in rescue-inhaler use in another, and lung-function changes too small to matter¹³. With so few people and some design flaws, the reviewers called the evidence low in certainty. Weight loss may help, they concluded, but nobody can say how much¹³.

Vitamin d looked promising for a while. A 2019 analysis of 14 studies with 1,421 people suggested fewer attacks, mainly in adults with low vitamin D levels¹¹. Then a 2020 trial in 192 children with low levels found no protection against severe attacks¹¹.

A 2023 Cochrane review of 20 studies found that supplements didn’t reduce the share of people who had at least one attack, though few participants had severe asthma or low vitamin D levels¹⁰. A separate article in this series covers vitamin D in depth.

This article covers how the main options stack up, using our four-level evidence scale. “Evidence says no” here means tested and failed, not dangerous.

Approach	What studies found	Rating
Weight loss, for people with overweight or obesity	Four small trials: some symptom gains, low certainty13	Promising but early
Yoga	15 studies with 1,048 people: probably small gains in quality of life and symptoms11	Promising but early
Breathing retraining	May improve quality of life; probably doesn’t ease asthma symptoms10	Promising but early
Acupuncture added to usual care	Nine studies with 777 people: better symptoms, no change in lung function11	Promising but early
Fish oil (omega-3s)	16 small studies with 464 people: an airway-inflammation marker fell in four; symptoms and lung function inconclusive11	Promising but early
Vitamin D pills to prevent attacks	20 studies: no drop in the share of people with attacks; few had low levels10	Evidence says no, or unsafe
Selenium or soy isoflavones	Trials of 197 and 386 people found no overall benefit1011	Evidence says no, or unsafe
Herbal products	A 2010 review found too little evidence to recommend any10	Not enough evidence
Homeopathic asthma products sold over the counter	Not evaluated by the FDA for safety or effectiveness1012	Not enough evidence

A later article in this series covers breathing exercises and their limits.

Cautions before you add anything

Supplements can interact with medicines. NCCIH advises talking with your clinician before starting one if you take asthma medicine¹⁰. Omega-3s, for example, may interact with the blood thinner warfarin¹¹.

Be wary of homeopathic asthma products sold over the counter. The FDA has not evaluated them for safety or effectiveness¹⁰¹². Choosing one in place of a prescribed inhaler during an attack could cost precious time.

If you take montelukast, know that the FDA added a boxed warning to it in March 2020⁷. If you have questions about what that warning covers, ask your prescriber before making any change.

Many readers worry about steroids, and on one point GINA shares that concern. Its 2026 guide says the risk of side effects from steroid pills grows with each course, and that better inhaled treatment can cut how many courses people need⁶. In other words, a small daily dose of inhaled medicine can be a way to need fewer pills.

Where natural-health values fit

If you value prevention, asthma care rewards it. Knowing your zones, keeping a symptom diary and checking your peak flow are self-reliance in its most useful form⁹.

If you value a clean home, the trigger work in this article is real prevention, especially a smoke-free home and allergen steps aimed at what you react to⁷¹⁴. If you value movement and a healthy weight, the weight-loss trials included exercise, and yoga has modest support¹¹¹³.

And if you distrust quick fixes, apply that same skepticism to every bottle. NCCIH found no supplement that has clearly been shown to help asthma, from herbs to vitamins¹². The approach with the best evidence pairs a few proven medicines with healthy habits, not one in place of the other.

Questions readers ask

The bottom line

Global asthma guidance has moved away from a rescue inhaler alone, because relying on one goes with more attacks and heavy use goes with a higher risk of death. U.S. guidance pairs relief with a steroid for many people with persistent asthma, though it still allows a rescue inhaler alone for the mildest cases. Know your zones, know the 911 signs, and review your plan if your only medicine is a rescue inhaler.

Natural approaches have a real place. Clearing smoke and targeted allergens from your home, moving more, losing weight if you have obesity, and calming practices such as yoga can support control. None of them has been shown to replace the medicines that keep airways open and inflammation down.

Related reading

• Where indoor allergens hide, and why no dog breed has earned the hypoallergenic label
• A fake inhaler made asthma patients feel better while their lungs showed no change
• Breathing takes care of itself in most workouts, but lifting, side stitches and asthma need a plan
• Watching your breath eases stress a little, while forceful breathwork near water can kill
• The symptoms that mean call 911 now

Sources

1. Centers for Disease Control and Prevention. “Most Recent Asthma Data.” CDC, updated October 6, 2026. cdc.gov
2. Pate CA, Zahran HS. “The Status of Asthma in the United States.” Preventing Chronic Disease, 2024;21:E53. cdc.gov
3. U.S. Environmental Protection Agency. “Asthma Facts” (EPA-402-F-25-001). EPA, May 2025. epa.gov
4. The Lancet Respiratory Medicine. “2025 GINA report for asthma.” Lancet Respir Med, 2025;13:e41-e42, doi:10.1016/S2213-2600(25)00242-5 (copy hosted by the Illinois Department of Healthcare and Family Services; journal page not re-opened). hfs.illinois.gov
5. O’Rourke G. “GINA axes SABA-only for children in 2026 update.” The Limbic (medical trade press), June 9, 2026. thelimbic.com
6. Global Initiative for Asthma. “Summary Guide for Asthma Management and Prevention” (based on the 2026 GINA Strategy Report published May 5, 2026). GINA, July 2026. ginasthma.org
7. National Heart, Lung, and Blood Institute. “2020 Focused Updates to the Asthma Management Guidelines: Clinician’s Guide.” NIH, December 2020.
8. MedlinePlus, National Library of Medicine. “Signs of an asthma attack.” Reviewed January 14, 2026. medlineplus.gov
9. Minnesota Department of Health. “Asthma Action Plan” (adult form). MDH. health.mn.gov
10. National Center for Complementary and Integrative Health. “Asthma and Complementary Health Approaches: What You Need To Know.” NCCIH, last updated March 2022. nccih.nih.gov
11. National Center for Complementary and Integrative Health. “Asthma and Complementary Health Approaches: What the Science Says.” NCCIH Clinical Digest, May 2022. nccih.nih.gov
12. National Center for Complementary and Integrative Health. “5 Things To Know About Asthma and Complementary Health Approaches.” NCCIH, updated October 17, 2026. nccih.nih.gov
13. Adeniyi FB, Young T. “Weight loss interventions for chronic asthma” (plain-language summary, CD009339). Cochrane Database of Systematic Reviews; summary page dated May 1, 2022; studies searched through March 2012. cochrane.org
14. U.S. Environmental Protection Agency. “Asthma Triggers: Gain Control.” EPA, updated July 6, 2026. epa.gov
15. National Heart, Lung, and Blood Institute. “Asthma: A T-A-G Lance” (NIH Publication No. 09-7429). NHLBI, 2009. medschool.lsuhsc.edu